Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Does Saffron Supplementation Have Favorable Effects on Liver Function Indicators? a Systematic Review and Meta-Analysis of Randomized Controlled Trials Publisher Pubmed



Mousavi SM1 ; Mokhtari P2 ; Asbaghi O3 ; Rigi S1 ; Persad E4 ; Jayedi A5 ; Rezvani H6 ; Mahamatsaleh Y7 ; Sadeghi O1, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Nutrition and Integrative Physiology, College of Health, University of Utah, Salt Lake City, UT, United States
  3. 3. Nutritional Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  4. 4. Department for Evidence-based Medicine and Evaluation, Danube University Krems, Krems, Austria
  5. 5. Food Safety Research Center (salt), Semnan University of Medical Sciences, Semnan, Iran
  6. 6. Department of Medical Oncology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  7. 7. CESP, Fac. de medecine - Univ. Paris-Sud, Fac. de medecine - UVSQ, INSERM, Universite Paris Saclay, Villejuif, France
  8. 8. Cellular and Molecular Gerash Research Center, Gerash University of Medical Sciences, Gerash, Iran

Source: Critical Reviews in Food Science and Nutrition Published:2022


Abstract

Several pharmaceutical and non-pharmaceutical approaches have been suggested to improve liver health. There is a large discrepancy in the effects of saffron supplementation on liver function in adults. To fill this knowledge gap, this systematic review and meta-analysis of randomized controlled trials (RCTs) assess the effects of saffron supplementation on liver enzymes alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). A systematic search current to August 2020 was performed in PubMed/Medline, Scopus, Web of Science, and Google Scholar using relevant keywords to detect eligible articles. A random-effects model was used to estimate the weighted mean difference (WMD) and 95% confidence (95% CI). Nine eligible trials were included in the final analysis. The pooled analysis revealed that serum ALT concentrations were significantly reduced using saffron compared to placebo (WMD: −2.39 U/L; 95% CI: −4.57 to −0.22; P = 0.03, I2 = 87.9%, P < 0.001). However, saffron supplementation did not affect levels of serum AST (WMD: 1.12 U/L; 95% CI: −1.42 to 3.65; P = 0.39) or ALP (WMD: 4.32 U/L; 95% CI: −6.91 to 15.54; P = 0.78). In the dose-response analysis, we did not find a significant dose-response relationship between dosage and duration of saffron supplementation on serum levels of ALT, AST, and ALP. We found that saffron supplementation can reduce ALT serum concentrations without significant effects on other liver function indicators, including AST and ALP. Nevertheless, future large RCTs on diverse populations are needed to understand better the effects of saffron and its constituents on these enzymes. © 2021 Taylor & Francis Group, LLC.
Experts (# of related papers)
Other Related Docs
21. Application of Saffron As a Neuroprotective Agent, Saffron: Science# Technology and Health (2020)